Natalizumab: a double-edged sword?
作者信息
DeAngelis Lisa M
出版信息
Ann Neurol. 2009 Sep;66(3):262-3. doi: 10.1002/ana.21813.
PMID:19798644
Abstract
摘要
相似文献
1
Natalizumab: a double-edged sword?那他珠单抗：一把双刃剑？
Ann Neurol. 2009 Sep;66(3):262-3. doi: 10.1002/ana.21813.
2
Natalizumab, multiple sclerosis, and primary central nervous system lymphoma: enigma, wrapped in mystery, enclosed in conundrum.那他珠单抗、多发性硬化症与原发性中枢神经系统淋巴瘤：谜团重重，错综复杂。
Ann Neurol. 2009 Sep;66(3):259-61. doi: 10.1002/ana.21850.
3
Natalizumab and central nervous system lymphoma: no clear association.
Ann Neurol. 2009 Sep;66(3):261-2. doi: 10.1002/ana.21835.
4
[Natalizumab in multiple sclerosis].[那他珠单抗治疗多发性硬化症]
Ideggyogy Sz. 2008 May 30;61(5-6):204-8.
5
Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis.进行性多灶性白质脑病、那他珠单抗与多发性硬化症
N Engl J Med. 2005 Oct 20;353(16):1744-6; author reply 1744-6. doi: 10.1056/NEJMc052311.
6
Another complication of natalizumab treatment? Taking the challenge.那他珠单抗治疗的另一个并发症？迎接挑战。
Ann Neurol. 2009 Sep;66(3):264-6. doi: 10.1002/ana.21842.
7
[Natalizumab in multiple sclerosis: unclear patient benefits].那他珠单抗治疗多发性硬化症：患者获益不明
Ned Tijdschr Geneeskd. 2007 Apr 14;151(15):852-5.
8
Balancing risk and reward: the question of natalizumab.权衡风险与收益：那他珠单抗的问题
Ann Neurol. 2009 Sep;66(3):A7-8. doi: 10.1002/ana.21873.
9
Primary central nervous system lymphoma in a patient treated with natalizumab.一名接受那他珠单抗治疗的患者发生原发性中枢神经系统淋巴瘤。
Ann Neurol. 2009 Sep;66(3):403-6. doi: 10.1002/ana.21782.
10
Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS.多发性硬化症患者接受那他珠单抗治疗期间进展性多灶性白质脑病的惰性病程
Neurology. 2011 Feb 8;76(6):574-6. doi: 10.1212/WNL.0b013e31820b7644.
Zotero 插件